KPV: The Anti-Inflammatory Tripeptide

Research on NF-kB inhibition and immune modulation

KPV is a tripeptide (Lysine-Proline-Valine) derived from alpha-MSH (alpha-melanocyte stimulating hormone). It's studied primarily for its potent anti-inflammatory properties, working through direct inhibition of the NF-kB inflammatory pathway.

The NF-kB Connection

A 2019 Nature Medicine study reported that chronic inflammation predicts mortality risk more accurately than traditional markers like cholesterol or blood pressure. KPV targets this inflammation at its source.

When tissue damage or infection occurs:

Pattern recognition receptors detect injury signals
NF-kB inflammatory signaling activates
Cells release inflammatory cytokines (IL-6, TNF-alpha, IL-1beta)
Cytokines cause redness, swelling, pain, and tissue damage

KPV inhibits NF-kB directly, suppressing this cascade at the source rather than just masking symptoms.

Key Mechanisms

NF-kB Inhibition

KPV directly inhibits NF-kB inflammatory signaling, reducing production of inflammatory cytokines including IL-6, TNF-alpha, and IL-1beta. This addresses the root mechanism driving chronic inflammation.

NF-kB Inhibition Cytokine Suppression Inflammasome Regulation

Mast Cell Stabilization

KPV stabilizes mast cells, preventing degranulation and the release of histamine and other inflammatory mediators. This is particularly relevant for allergic conditions and skin disorders.

Mast Cell Stabilization Histamine Control Allergic Response

Brain & Neuroinflammation

In the brain, chronic inflammation activates microglia - the immune cells of the nervous system. Persistent microglial activation is associated with neurodegenerative conditions. KPV reduces microglial NF-kB activation in research models.

Microglial Modulation Neuroinflammation Neuroprotection

Conditions Researched

KPV has been studied for inflammatory conditions including:

Other researched conditions: rosacea, autoimmune skin conditions, tinnitus, atherosclerosis, systemic lupus erythematosus, and endometriosis.

TH1/TH2 Immune Balance

Many inflammatory conditions involve TH2 immune dominance - an imbalanced immune response that favors allergic reactions. KPV helps restore TH1/TH2 balance:

Suppresses excessive TH2 signaling
Reduces IL-4 and IL-5 cytokine release
Inhibits TSLP signaling that initiates allergic cascades

Synergistic Combinations

KPV is often researched alongside other peptides:

KPV + BPC-157: Inflammation control + tissue repair
KPV + Thymosin Alpha-1: Dual immune modulation
KPV + GHK-Cu: Anti-inflammatory + antioxidant support

Explore KPV Research

Search our knowledge base for specific conditions and mechanisms.

Open Knowledge Base